论文部分内容阅读
目的分析急性型特发性血小板减少性紫癜患儿的临床治疗效果。方法本组研究对象为2012年2月~2014年2月儿科收治入院的18例急性型特发性血小板减少性紫癜患儿。随机分成对照组和观察组,每组病例各9例。结果治疗后,两组治疗效果对比有差异,P<0.05。结论特发性血小板减少性紫癜急性型多见于2~8岁儿童,男女发病无差异。初始治疗患儿给予糖皮质激素治疗效果显著,地塞米松冲击疗法能使患儿的血小板水平在6~7日恢复到正常水平,使患儿平安度过严重出血危险期。
Objective To analyze the clinical effect of acute idiopathic thrombocytopenic purpura in children. Methods The subjects of this study were 18 children with acute idiopathic thrombocytopenic purpura admitted to pediatrics from February 2012 to February 2014. Randomly divided into control group and observation group, 9 cases in each group. Results After treatment, there was a significant difference in the therapeutic effect between the two groups (P <0.05). Conclusions Idiopathic thrombocytopenic purpura acute type more common in children aged 2 to 8 years, no difference in the incidence of men and women. Initial treatment of children given glucocorticoid treatment is significant, dexamethasone impact therapy can make children’s platelet levels returned to normal levels 6 to 7, so that children safely over the risk of severe bleeding.